A detailed history of Public Sector Pension Investment Board transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Public Sector Pension Investment Board holds 68,341 shares of COLL stock, worth $2.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,341
Previous 71,941 5.0%
Holding current value
$2.25 Million
Previous $2.32 Million 13.99%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$31.4 - $39.07 $113,040 - $140,652
-3,600 Reduced 5.0%
68,341 $2.64 Million
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $159,779 - $203,749
5,095 Added 7.62%
71,941 $2.32 Million
Q1 2024

May 14, 2024

SELL
$31.23 - $40.91 $25,920 - $33,955
-830 Reduced 1.23%
66,846 $2.59 Million
Q4 2023

Feb 14, 2024

BUY
$21.16 - $30.8 $523,604 - $762,146
24,745 Added 57.64%
67,676 $2.08 Million
Q3 2023

Nov 22, 2023

SELL
$21.23 - $24.28 $399,293 - $456,658
-18,808 Reduced 30.46%
42,931 $959,000
Q2 2023

Aug 14, 2023

BUY
$21.06 - $24.0 $56,735 - $64,656
2,694 Added 4.56%
61,739 $1.33 Million
Q1 2023

May 12, 2023

SELL
$23.0 - $29.88 $46,736 - $60,716
-2,032 Reduced 3.33%
59,045 $1.42 Million
Q4 2022

Feb 14, 2023

SELL
$16.14 - $23.55 $29,245 - $42,672
-1,812 Reduced 2.88%
61,077 $1.42 Million
Q2 2022

Aug 12, 2022

SELL
$14.22 - $20.88 $25,752 - $37,813
-1,811 Reduced 2.8%
62,889 $1.11 Million
Q1 2022

May 13, 2022

SELL
$17.2 - $22.5 $98,212 - $128,475
-5,710 Reduced 8.11%
64,700 $1.32 Million
Q4 2021

Feb 14, 2022

SELL
$17.5 - $21.35 $22,575 - $27,541
-1,290 Reduced 1.8%
70,410 $1.32 Million
Q1 2021

May 14, 2021

BUY
$19.25 - $26.1 $1.38 Million - $1.87 Million
71,700 New
71,700 $1.7 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.